These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 38786070)
1. Current and Future Therapeutics for Treating Patients with Sickle Cell Disease. Barak M; Hu C; Matthews A; Fortenberry YM Cells; 2024 May; 13(10):. PubMed ID: 38786070 [TBL] [Abstract][Full Text] [Related]
9. Advances in the diagnosis and treatment of sickle cell disease. Brandow AM; Liem RI J Hematol Oncol; 2022 Mar; 15(1):20. PubMed ID: 35241123 [TBL] [Abstract][Full Text] [Related]
10. Defining curative endpoints for sickle cell disease in the era of gene therapy and gene editing. Locatelli F; Corbacioglu S; Hobbs W; Frangoul H; Walters MC Am J Hematol; 2024 Mar; 99(3):430-438. PubMed ID: 38010293 [TBL] [Abstract][Full Text] [Related]
11. Interventions for chronic kidney disease in people with sickle cell disease. Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087 [TBL] [Abstract][Full Text] [Related]
12. Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453 [TBL] [Abstract][Full Text] [Related]
13. Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Doree C; Abboud MR Cochrane Database Syst Rev; 2017 May; 5(5):CD012389. PubMed ID: 28500860 [TBL] [Abstract][Full Text] [Related]
14. Voxelotor for the treatment of sickle cell disease in pediatric patients. Brown C; Tonda M; Abboud MR Expert Rev Hematol; 2022 Jun; 15(6):485-492. PubMed ID: 35671094 [TBL] [Abstract][Full Text] [Related]
15. Cellular therapy for sickle cell disease. Abraham A; Jacobsohn DA; Bollard CM Cytotherapy; 2016 Nov; 18(11):1360-1369. PubMed ID: 27421743 [TBL] [Abstract][Full Text] [Related]
17. Emerging drugs for the treatment of sickle cell disease: a review of phase II/III trials. Ross JM; Forté S; Soulières D Expert Opin Emerg Drugs; 2022 Jun; 27(2):211-224. PubMed ID: 35912835 [TBL] [Abstract][Full Text] [Related]
18. Current state of gene therapy in sickle cell disease. Tang MS; Shan H Vox Sang; 2024 Jun; 119(6):521-528. PubMed ID: 38487952 [TBL] [Abstract][Full Text] [Related]
19. An expert review of voxelotor for the treatment of hemolytic anemia in patients with sickle cell disease: 'bridging the gap between laboratory data and patient related outcomes'. Inusa BPD; Mnika K; Babiker S Expert Rev Hematol; 2023; 16(8):585-591. PubMed ID: 37329253 [TBL] [Abstract][Full Text] [Related]